Covered recipient · General Payments record
REETESH K PAI
Allopathic & Osteopathic Physicians Pathology Anatomic Pathology & Clinical Pathology
General Payments · PY2018–2024
$155,900.00
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $56,000.00 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ARENA PHARMACEUTICALS, INC. | $34,100.00 | 6 |
| MEDIVATION INC. | $12,600.00 | 3 |
| Acerta Pharma LLC | $9,300.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ARENA PHARMACEUTICALS, INC. | $13,200.00 | 02/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131904459 | CMS |
| ARENA PHARMACEUTICALS, INC. | $4,000.00 | 02/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131904461 | CMS |
| ARENA PHARMACEUTICALS, INC. | $1,700.00 | 02/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131904741 | CMS |
| ARENA PHARMACEUTICALS, INC. | $10,800.00 | 05/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131902617 | CMS |
| ARENA PHARMACEUTICALS, INC. | $3,900.00 | 05/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131902619 | CMS |
| ARENA PHARMACEUTICALS, INC. | $500.00 | 05/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131904743 | CMS |
| AstraZeneca Pharmaceuticals LP | $9,300.00 | 02/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105555564 | CMS |
| MEDIVATION LLC. | $5,100.00 | 08/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131649206 | CMS |
| MEDIVATION LLC. | $300.00 | 08/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131649210 | CMS |
| MEDIVATION LLC. | $7,200.00 | 08/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131653396 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.